Temasek invests in AEM Look past 1H21 normalisation; BUY1H21 PATMI of SGD29.5m (-46.6% YoY) was in line with our estimate butfell short of consensus'. The weakness was due to high base effects as AEMhad new products in 1H20. Our P&L forecasts are unchanged, but we trimFY21-23E EPS by 3-9% to account for dilution from the […]

Read more of this post